Cosan (CSAN3) said on Wednesday, November 11, 2026, that it is holding talks about a possible partial divestment of its stake in Rumo. The company says it remains open to evaluating different alternatives and transaction structures. The statement was released after a Brazil Journal report titled "Cosan may revisit Rumo's 'poison pill'".
The report mentions the alleged removal of the poison pill, a provision in Rumo's bylaws that protects its dispersed share ownership (preventing the concentration of shares in the hands of a few shareholders). Cosan does not confirm the removal. According to the company, any discussions on the provision must observe the applicable corporate requirements, including a resolution by Rumo's shareholders at an Extraordinary General Meeting.
Cosan said it will keep shareholders and the market informed of any developments related to the matter.
Is CSAN3 worth investing in?
- Price
- R$ 2.68
- as of 11/10/2026
- Dividend yield
- 0.00 %
- P/L
- N/A
- P/VPA
- 2.13
